SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Kia, L. Kelly, R. L. C. Sison-Young, F. Zhang, C. S. Pridgeon, J. A. Heslop, P. Metcalfe, N. R. Kitteringham, M. Baxter, S. Harrison, N. A. Hanley, Z. D. Burke, M. P. Storm, M. J. Welham, D. Tosh, B. Kuppers-Munther, J. Edsbagge, P. J. Starkey Lewis, F. Bonner, E. Harpur, J. Sidaway, J. Bowes, S. W. Fenwick, H. Malik, C. E. P. Goldring, B. K. Park, MicroRNA-122: A Novel Hepatocyte-Enriched in vitro Marker of Drug-Induced Cellular Toxicity, Toxicological Sciences, 2015, 144, 1, 173

    CrossRef

  2. 2
    Martien van Wenum, Robert AFM Chamuleau, Thomas M van Gulik, Adriaan Siliakus, Jurgen Seppen, Ruurdtje Hoekstra, Bioartificial liversin vitroandin vivo: tailoring biocomponents to the expanding variety of applications, Expert Opinion on Biological Therapy, 2014, 14, 12, 1745

    CrossRef

  3. 3
    M José Gómez-Lechón, Laia Tolosa, Isabel Conde, M Teresa Donato, Competency of different cell models to predict human hepatotoxic drugs, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 11, 1553

    CrossRef

  4. 4
    Anna-Karin M. Sjogren, Maria Liljevald, Björn Glinghammar, Johanna Sagemark, Xue-Qing Li, Anna Jonebring, Ian Cotgreave, Gabriella Brolén, Tommy B. Andersson, Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes, Archives of Toxicology, 2014, 88, 7, 1427

    CrossRef

  5. 5
    David A Mann, Human induced pluripotent stem cell-derived hepatocytes for toxicology testing, Expert Opinion on Drug Metabolism & Toxicology, 2014, 1

    CrossRef

  6. 6
    Sabine Gerbal-Chaloin, Natalie Funakoshi, Amandine Caillaud, Claire Gondeau, Benoite Champon, Karim Si-Tayeb, Human Induced Pluripotent Stem Cells in Hepatology, The American Journal of Pathology, 2014, 184, 2, 332

    CrossRef

  7. 7
    Robim M. Rodrigues, Agapios Sachinidis, Veerle De Boe, Vera Rogiers, Tamara Vanhaecke, Joery De Kock, Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors, Toxicology in Vitro, 2014,

    CrossRef

  8. 8
    Minjun Chen, Halil Bisgin, Lillian Tong, Huixiao Hong, Hong Fang, Jürgen Borlak, Weida Tong, Toward predictive models for drug-induced liver injury in humans: are we there yet?, Biomarkers in Medicine, 2014, 8, 2, 201

    CrossRef

  9. 9
    James H. Lewis, Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist, Pharmaceutical Medicine, 2013, 27, 3, 165

    CrossRef

  10. 10
    Cliff Rowe, Dave T. Gerrard, Roz Jenkins, Andrew Berry, Kesta Durkin, Lars Sundstrom, Chris E. Goldring, B. Kevin Park, Neil R. Kitteringham, Karen Piper Hanley, Neil A. Hanley, Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation, Hepatology, 2013, 58, 2
  11. 11
    Ruth McKernan, Fiona M Watt, What is the point of large-scale collections of human induced pluripotent stem cells?, Nature Biotechnology, 2013, 31, 10, 875

    CrossRef